Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Michaela C. Huber"'
Autor:
Rebecca Mall, Katrin Lindner, Herbert Braselmann, Michaela Aubele, Sara Molatore, Axel Walch, Eva Gross, Manfred Schmitt, Annette Feuchtinger, Michaela C. Huber, Natalie Falkenberg
Publikováno v:
BMC Cancer
BMC Cancer 16:615 (2016)
BMC Cancer 16:615 (2016)
Background Due to lack of a targeted therapy for the triple-negative breast cancer (TNBC) patients, it is important to explore this aggressive breast cancer type in more detail and to establish novel therapeutic approaches. TNBC is defined negative f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e7ead5fbab0d070dd5c795cb05740a6
https://doi.org/10.1186/s12885-016-2663-9
https://doi.org/10.1186/s12885-016-2663-9
Autor:
Michaela C. Huber, Herbert Braselmann, Annette Feuchtinger, Natalie Falkenberg, Stefanie M. Hauck, Axel Walch, Michaela Aubele, Markus Priller, Manfred Schmitt
Publikováno v:
Oncotarget
Oncotarget 7, 44062-44075 (2016)
Oncotarget 7, 44062-44075 (2016)
The triple-negative breast cancer (TNBC) is a very aggressive tumor type often occurring in young women and is associated with a bad prognosis for the patients. TNBC lacks established targets for breast cancer therapy, such as the estrogen receptor (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9336b388238182c56b40a7a9b8138d97
https://pubmed.ncbi.nlm.nih.gov/27286449
https://pubmed.ncbi.nlm.nih.gov/27286449
Autor:
Michaela C. Huber, Michaela Aubele, Manfred Schmitt, Natalie Falkenberg, Eva Gross, Axel Walch, Herbert Braselmann
Publikováno v:
Journal of Clinical Oncology. 33:150-150
150 Background: Triple-negative breast cancers (TNBC), which lack expression of estrogen (ER), progesterone (PR), and HER2 receptors are characterized by tumor tissue expression of the urokinase-type plasminogen activator receptor (uPAR) system. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9db690a273dd76acafcc42b66d9636b8
https://doi.org/10.1200/jco.2015.33.28_suppl.150
https://doi.org/10.1200/jco.2015.33.28_suppl.150
Autor:
Natalie Falkenberg, Gert Auer, Manfred Schmitt, Heinz Höfler, Michaela Aubele, Natasa Anastasov, Herbert Braselmann, Michaela C. Huber
Publikováno v:
Molecular Cancer Research. 11:A046-A046
Introduction: The expression of miR-221 and -222 is frequently altered in invasive breast cancer and in breast cancer cell lines. We aimed to determine the prognostic and/or therapeutic impact of miR-221/222 expression and its association with tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48efe14e037bac58b9050f33bd35b5a5
https://doi.org/10.1158/1557-3125.advbc-a046
https://doi.org/10.1158/1557-3125.advbc-a046